Colony Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$214K Sell
7,614
-147
-2% -$5.05K ﹤0.01% 717
2023
Q2
$286K Buy
7,761
+190
+3% +$5.8K ﹤0.01% 679
2023
Q1
$227K Sell
7,571
-11
-0.1% -$362 ﹤0.01% 721
2022
Q4
$232K Buy
+7,582
New +$228K ﹤0.01% 765
2022
Q3
Sell
-7,659
Closed -$245K 782
2022
Q2
$245K Buy
+7,659
New +$282K ﹤0.01% 737

Other funds holding CC

Colony Group's CC Position: Q3 2023 in Review

Colony Group reduced its Chemours (CC) stake by 1.9% in Q3 2023, selling an estimated $5.05K and leaving 7,614 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Colony Group first reported a position in CC in Q2 2022 and has held it in 5 quarters since. The position peaked at $286K in Q2 2023. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Colony Group held 7,614 shares of Chemours worth $214K as of Q3 2023.
  • Colony Group sold 147 Chemours shares in Q3 2023, an estimated $5.05K.
  • Chemours made up ﹤0.01% of Colony Group's portfolio in Q3 2023, its #717 holding.
  • Colony Group first reported a position in Chemours in Q2 2022 and has held it in 5 quarters since.
  • Colony Group's Chemours position peaked at $286K in Q2 2023.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.